Through this partnership, BLAST will be able to use Corpay Cross-Border’s innovative solutions to help mitigate foreign exchange exposure in their daily operations. They’ll also benefit from Corpay’s ...

Latest research from Omdia shows that the Southeast Asia’s smartphone market declined 1% in 3Q25, with shipments totaling ...

European Commission (EC) has granted marketing authorization for Remsima™ IV (intravenous) liquid formulation, the world’s first liquid formulation of IV infliximab. Approved in 100 mg and 350 mg ...

The first IDEAL Japan agreement was signed with the National Cancer Center Japan. Through this first project that has just entered the program, Debiopharm will fund discovery research targeting colon ...

Founded in 2008, Cinemo provides world-leading digital media solutions for the highly demanding automotive market. Trusted by more than 40 market-leading OEMs and over 20 tier-1 suppliers, Cinemo has ...

The European Commission (EC) has granted a line extension in the European Union (EU) for Celltrion’s Omlyclo™ (omalizumab), Europe’s first and only omalizumab biosimilar, for the 300 mg/2ml prefilled ...

Ant International has been an Ensemble Sandbox participant since 2024, where it leveraged its internal next-generation treasury solution the Whale platform to participate in two use cases under the ...

Bettr, a leading provider of inclusive financial services and technology business under Ant International, today announced the launch of its proprietary tailored, one-stop credit tech solutions ...

Mitsui Chemicals, Inc. has announced that online applications for the 2026 Mitsui Chemicals Catalysis Science Award have been open since September 1, 2025. The application period will run from ...

Access Advance LLC, an independent licensing administrator for leading video codec patent pools, today announced that Xiaomi has joined the HEVC Advance Patent Pool and the VVC Advance Patent Pool, as ...

Avanzanite Bioscience B.V. (Avanzanite), a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today announced a €32 million Series A growth investment ...

Operating as an independent, mission-driven organization, BRIDGE Alliance reinvests all operational surpluses into advancing research, capacity building, and innovation. It aims to enhance cooperation ...